Abbvie Inc

NYSE: ABBV
$166.41
+$1.75 (+1.1%)
Closing price April 19, 2024
Abbvie Inc. is a global pharmaceutical company that focuses on discovering, developing, manufacturing, and selling a wide range of treatments. Its portfolio includes therapies for autoimmune diseases, various cancers, eye diseases, neurological disorders, and more. Notable products include Humira for autoimmune conditions, Skyrizi and Rinvoq for skin and joint diseases, and Imbruvica for blood cancers. AbbVie also offers products in aesthetics, women's health, and eye care. Founded in 2012 and based in North Chicago, Illinois, AbbVie collaborates with several biotech firms to advance its research in oncology and immunology.
Before U.S. markets open on Friday, the country's two largest oil and gas companies will report earnings.
These seven top Dividend Aristocrats have been out of favor. Yet they are all trading at quite reasonable levels, pay generous and dependable dividends, and are solid and safe ideas in the current...
Monday's top analyst upgrades and downgrades included AbbVie, Adobe, Advance Auto Parts, Anheuser-Busch InBev, Bumble, Fortinet, Nike and Palo Alto Networks.
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
These seven big-dividend stocks offer growth if the market continues higher, but also a degree of safety if the AI-driven bubble bursts and market declines and volatility return, as J.P. Morgan warns...
Before U.S. markets open on Thursday, these three firms will be reporting quarterly results.
Any company that has paid rising dividends for 50 years or more is the epitome of safe and dependable. These seven outstanding safe-haven Dividend Kings also have support from top Wall Street...
These seven top Dividend Aristocrats are trading at reasonable levels, pay dependable dividends and, most of all, are solid and safe ideas in a market that looks poised to trade lower after a big run...
Two pharmaceutical giants, one a Dow component, report quarterly results before markets open on Thursday. A major airline and a tobacco company are also on the schedule.
Thursday's top analyst upgrades and downgrades included AbbVie, AutoZone, Boeing, Coupang, First Solar, Fortinet, Goldman Sachs, Johnson & Johnson, Marqeta, Monster Beverage, Rivian Automotive,...
Here are seven top Dividend Aristocrats with among the largest dividends that retirement-focused investors can buy now and hold forever. They are all trading at very reasonable levels and offer...
Monday's top analyst upgrades and downgrades included AbbVie, Affirm, Bloom Energy, FREYR Battery, International Flavors & Fragrances, Interpublic Group of Companies, Lyft, Micron Technology,...
Before U.S. markets open on Thursday, AbbVie, Cameco, Canopy Growth, PepsiCo and Under Armour will report quarterly earnings.
After a big fall rally and with interest rates still rising, it makes sense now to look for top value stocks with healthy and dependable dividends. These five look like solid portfolio additions for...
Any company that has paid dividends for 50 consecutive years is the epitome of safe and dependable. These seven Dividend Kings also have support from top Wall Street analysts, making them outstanding...